YTHDC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.263800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.450200E-01
Normal-vs-Stage2
1.815820E-02
Normal-vs-Stage3
2.768000E-02
Normal-vs-Stage4
8.141200E-01
Stage1-vs-Stage2
1.925350E-01
Stage1-vs-Stage3
1.279010E-03
Stage1-vs-Stage4
5.434800E-01
Stage2-vs-Stage3
3.973700E-02
Stage2-vs-Stage4
3.318200E-02
Stage3-vs-Stage4
4.224100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.763900E-02
Normal-vs-AfricanAmerican
1.490620E-01
Normal-vs-Asian
4.105700E-02
Caucasian-vs-AfricanAmerican
7.971400E-01
Caucasian-vs-Asian
2.204200E-01
AfricanAmerican-vs-Asian
5.990600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.033800E-02
Normal-vs-Female
3.306200E-02
Male-vs-Female
8.994800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.168400E-01
Normal-vs-Age(41-60Yrs)
8.294400E-02
Normal-vs-Age(61-80Yrs)
2.918400E-02
Normal-vs-Age(81-100Yrs)
1.920230E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.442600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.845600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.331600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.301000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.230090E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.202000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.067660E-02
Normal-vs-Daily Drinker
2.283500E-02
Normal-vs-Weekly Drinker
2.029900E-02
Normal-vs-Occasional Drinker
1.464970E-01
Normal-vs-Social Drinker
1.249600E-01
Non Drinker-vs-Daily Drinker
9.185000E-01
Non Drinker-vs-Weekly Drinker
4.721200E-01
Non Drinker-vs-Occasional Drinker
4.406300E-02
Non Drinker-vs-Social Drinker
1.292820E-01
Daily Drinker-vs-Weekly Drinker
5.799600E-01
Daily Drinker-vs-Occasional Drinker
6.378400E-02
Daily Drinker-vs-Social Drinker
1.578980E-01
Weekly Drinker-vs-Occasional Drinker
3.126500E-02
Weekly Drinker-vs-Social Drinker
7.978400E-02
Occasional Drinker-vs-Social Drinker
7.369800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.582000E-02
Normal-vs-Grade 2
1.618170E-03
Normal-vs-Grade 3
9.249300E-04
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.012800E-01
Grade 1-vs-Grade 3
9.757000E-01
Grade 1-vs-Grade 4
5.582000E-02
Grade 2-vs-Grade 3
8.658200E-01
Grade 2-vs-Grade 4
1.618170E-03
Grade 3-vs-Grade 4
9.249300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.642430E-02
Normal-vs-NonDiabetic
2.629800E-02
Diabetic-vs-NonDiabetic
2.985600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.645980E-02
Normal-vs-NoPancreatitis
2.603700E-02
Pancreatitis-vs-NoPancreatitis
4.938400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.129360E-01
Normal-vs-N1
1.863500E-02
N0-vs-N1
6.700800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.736000E-01
Normal-vs-TP53-NonMutant
2.320000E-01
TP53-Mutant-vs-TP53-NonMutant
4.814600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
